Novartis AG Share Price Today: Live Updates & Key Insights
Novartis AG share price today is $146.09, up -1.46%. The stock opened at $148.77 against the previous close of $148.19, with an intraday high of $148.9 and low of $145.3.
Novartis AG Share Price Chart
Novartis AG
Novartis AG Share Price Performance
Novartis AG Institutional Holdings
Novartis AG Market Status
Novartis AG Fundamentals
Market Cap 282286.26 M
PB Ratio 6.0405
PE Ratio 20.3953
Enterprise Value 302072.55 M
Total Assets 115569.20 M
Volume 2019872
Novartis AG Company Financials
About Novartis AG & investment objective
Company Information Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of myelofibrosis, polycythemia vera, and acute or chronic graftversushost disease (GvHD). It also provides Tasigna to treat philadelphia chromosomepositive chronic myeloid leukemia in the chronic and/or accelerated phase; Xolair for the treatment of allergic asthma and nasal polyps or severe chronic rhinosi nusitis with nasal polyps; Ilaris to treat fever syndromes, Still's disease, and acute gouty arthritis; Pluvicto to treat prostatespecific membrane anti genpositive metastatic castrationresistant prostate cancer; Sandostatin SC and Sandostatin LAR to treat acromegaly carcinoid tumors and other types of functional gastro intestinal and pancreatic neuroendocrine tumors; Zolgensma for the treatment of genetic root cause of spinal muscular atrophy; Lucentis; Leqvio to reduce LDL cholesterol; Lutathera; Scemblix; and Fabhalta. The company focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, oncology, and hematology. It has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. to develop, manufacture, and commercialize Leqvio (inclisiran), a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Organisation Drug Manufacturers - General
Employees 75267
Industry Drug Manufacturers - General
CEO null
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Novartis AG FAQs
What is the share price of Novartis AG today?
The current share price of Novartis AG is $146.09.
Can I buy Novartis AG shares in India?
Yes, Indian investors can buy Novartis AG shares by opening an international trading and demat account with Motilal Oswal.
How to buy Novartis AG shares in India?
You can easily invest in Novartis AG shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Novartis AG shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Novartis AG.
Can I buy fractional shares of Novartis AG?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Novartis AG?
Novartis AG has a market cap of $282286.26 M.
In which sector does Novartis AG belong?
Novartis AG operates in the Drug Manufacturers - General sector.
What documents are required to invest in Novartis AG stocks?
To invest, you typically need:
What is the PE and PB ratio of Novartis AG?
The PE ratio of Novartis AG is 20.40 and the PB ratio is 6.04.